Bing Jie Chow

Mr. Bing Jie Chow

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2025 in Bioengineering
Verified
Journal Article
Open access
PDF file
BCBing Jie Chow
Bing Jie Chow
CLChang Liu
Chang Liu
MYMingyi Yu
Mingyi Yu
ILIsabelle Lee
Isabelle Lee
Jodhbir S. MehtaJodhbir S. Mehta
Jodhbir S. Mehta
YLYu Chi Liu
Yu Chi Liu
Terahertz (THz) waves reside in the electromagnetic spectrum between the microwave and infrared bands. In recent decades, THz technology has demonstrated its potential for biomedical applications. With the highly unique characteristics of THz waves, such as the high sensitivity to water and optimal spatial resolution coupled with the characteristics of the human cornea, such as its high water content, THz technology has been explored as a potential modality to assess corneas and corneal diseases. This systematic review provides an overview of the characteristics of THz waves, the safety profile of THz technology in the field of ophthalmology, and its clinical applications, including the objective evaluation of the corneal hydration, tear film, dry eye disease, corneal endothelium, corneal elasticity, and scarring. The paper also presents our viewpoint on the present challenges and future directions of THz technology prior to its broader integration into clinical practice.

31 January 2025 in BJU International
Verified
Journal Article
Open access
BCBing Jie Chow
Bing Jie Chow
ALAlexander Light
Alexander Light
ANArjun Nathan
Arjun Nathan
LBLoic Baekelandt
Loic Baekelandt
GMGautier Marcq
Gautier Marcq
BGBritish Urology Researchers in Surgical Training (BURST) in collaboration with the European Association of Urology Young Academic Urologists Urothelial Carcinoma Working Group
British Urology Researchers in Surgical Training (BURST) in collaboration with the European Association of Urology Young Academic Urologists Urothelial Carcinoma Working Group

20 March 2023 in The Journal of Vascular Access
Verified
Journal Article
Closed access
BCBing Jie Chow
Bing Jie Chow
PCPrashanth Chowdary
Prashanth Chowdary
MKMuhammad Khurram
Muhammad Khurram
IMIsmail H Mohamed
Ismail H Mohamed
Background: In haemodialysis patients with exhausted autogenous options, prosthetic arteriovenous grafts (AVGs) are frequently utilised as tertiary vascular access. However, the prosthetic nature of AVGs precipitates an increased risk of infection which may translate to excess morbidity and life-threatening complications. The current evidence remains divided on the optimal treatment strategy for arteriovenous graft infections (AVGi) with arguments for conservative management by antibiotics, salvaging with graft revision or total/subtotal excision. To address this gap, we assessed the outcomes of AVGi patients treated in our institution, developing an AVGi severity classification model and a proposed treatment algorithm to guide AVGi management. Methods: We conducted a single centre retrospective review of outcomes of patients with AVGi managed either by sole antibiotics therapy, graft revision or surgical excision between June 2016 and May 2021. Outcomes of AVGi patients across differing treatment groups were compared, including 1-year mortality, 6-month and 1-year functional vascular access. We also analysed the outcomes of tunnelled haemodialysis lines (THL), which were used as a temporary vascular access in several AVGi patients in our study. Results: A total of 34 AVGi patients were managed within that time frame and included in the study (5 conservatively management by antibiotics, 5 graft revisions and 24 surgical excision) with a mean age of 60.4 ± 14.4 years (67.6% males). Overall 1-year mortality was 14.7%. A 6-month functional vascular access status across the three groups stood at 60%, 60% and 10% while 1-year functional vascular access status was 60%, 75% and 42% respectively. Conclusions: When clinically appropriate, conservative management by antibiotics or salvage/graft revision can present as prudent AVGi treatment options. The adoption of our proposed severity classification system and treatment algorithm provides a more thorough objective assessment of the infection and helps guide the clinical decision-making process.

17 October 2024 in BJU International
Verified
Journal Article
Closed access
BCBing Jie Chow
Bing Jie Chow
RVRaghav Varma
Raghav Varma
NBNikita Bhatt
Nikita Bhatt
KBKevin Byrnes
Kevin Byrnes
Simona IppolitiSimona Ippoliti
Simona Ippoliti
VKVeeru Kasivisvinathan
Veeru Kasivisvinathan